These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22546719

  • 1. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Bulgaria before the introduction of pneumococcal conjugate vaccine.
    Setchanova LP, Alexandrova A, Mitov I, Nashev D, Kantardjiev T, Group for Microbiological Surveillance of Pneumococci.
    J Chemother; 2012 Feb; 24(1):12-7. PubMed ID: 22546719
    [Abstract] [Full Text] [Related]

  • 2. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E, Albert MJ.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [Abstract] [Full Text] [Related]

  • 3. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ, Klugman KP, Pichichero M.
    Pediatr Infect Dis J; 2007 Feb 31; 26(2):123-8. PubMed ID: 17259873
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM, Memish ZA, Al-Kattan KM.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [Abstract] [Full Text] [Related]

  • 5. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F, Smaoui H, Kechrid A.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [Abstract] [Full Text] [Related]

  • 6. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia.
    Mayanskiy N, Alyabieva N, Ponomarenko O, Lazareva A, Katosova L, Ivanenko A, Kulichenko T, Namazova-Baranova L, Baranov A.
    Int J Infect Dis; 2014 Mar 31; 20():58-62. PubMed ID: 24462930
    [Abstract] [Full Text] [Related]

  • 7. Serotype changes and antimicrobial nonsusceptibility rates of invasive and non-invasive Streptococcus pneumoniae isolates after implementation of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Bulgaria.
    Setchanova L, Murdjeva M, Stancheva I, Alexandrova A, Sredkova M, Stoeva T, Yoneva M, Kurchatova A, Mitov I.
    Braz J Infect Dis; 2017 Mar 31; 21(4):433-440. PubMed ID: 28472614
    [Abstract] [Full Text] [Related]

  • 8. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period.
    Kawaguchiya M, Urushibara N, Ghosh S, Kuwahara O, Morimoto S, Ito M, Kudo K, Kobayashi N.
    Microb Drug Resist; 2014 Oct 31; 20(5):456-65. PubMed ID: 24766085
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility profiles and correlation with pneumococcal serotypes soon after implementation of the 10-valent pneumococcal conjugate vaccine in Brazil.
    Mott M, Caierão J, Rosa da Cunha G, Rodrigues Perez LR, Matusiak R, Pilger de Oliveira KR, d'Azevedo PA, Dias C.
    Int J Infect Dis; 2014 Mar 31; 20():47-51. PubMed ID: 24389158
    [Abstract] [Full Text] [Related]

  • 10. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
    Okade H, Funatsu T, Eto M, Furuya Y, Mizunaga S, Nomura N, Mitsuyama J, Yamagishi Y, Mikamo H.
    J Infect Chemother; 2014 Jul 31; 20(7):423-8. PubMed ID: 24802765
    [Abstract] [Full Text] [Related]

  • 11. Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: The emergence of multidrug resistant serotype 6C.
    Neves FPG, Cardoso NT, Snyder RE, Marlow MA, Cardoso CAA, Teixeira LM, Riley LW.
    Vaccine; 2017 May 15; 35(21):2794-2800. PubMed ID: 28431817
    [Abstract] [Full Text] [Related]

  • 12. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S, Lee K.
    Diagn Microbiol Infect Dis; 2009 Feb 15; 63(2):213-6. PubMed ID: 19097840
    [Abstract] [Full Text] [Related]

  • 13. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
    Wierzbowski AK, Karlowsky JA, Adam HJ, Nichol KA, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance.
    J Antimicrob Chemother; 2014 Jan 15; 69(1):59-66. PubMed ID: 23970485
    [Abstract] [Full Text] [Related]

  • 14. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL, De La Hoz F, Díaz PL, Sanabria O, Realpe ME, Moreno J.
    Vaccine; 2013 Aug 20; 31(37):4033-8. PubMed ID: 23680440
    [Abstract] [Full Text] [Related]

  • 15. Dominance of multidrug-resistant Denmark(14)-32 (ST230) clone among Streptococcus pneumoniae serotype 19A isolates causing pneumococcal disease in Bulgaria from 1992 to 2013.
    Setchanova LP, Alexandrova A, Dacheva D, Mitov I, Kaneva R, Mitev V.
    Microb Drug Resist; 2015 Feb 20; 21(1):35-42. PubMed ID: 25080213
    [Abstract] [Full Text] [Related]

  • 16. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yoshioka CR, Gilio AE, Martinez MB.
    Vaccine; 2013 Dec 09; 31(51):6150-4. PubMed ID: 23747454
    [Abstract] [Full Text] [Related]

  • 17. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G, Lebanese Inter-Hospital Pneumococcal Surveillance Program.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [Abstract] [Full Text] [Related]

  • 18. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006-2010.
    Cho EY, Lee H, Choi EH, Kim YJ, Eun BW, Cho YK, Kim YK, Jo DS, Lee HS, Lee J, Kim MN, Kim DS, Lee HJ.
    Diagn Microbiol Infect Dis; 2014 Apr 31; 78(4):481-6. PubMed ID: 24529940
    [Abstract] [Full Text] [Related]

  • 19. European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.
    Navarro Torné A, Dias JG, Quinten C, Hruba F, Busana MC, Lopalco PL, Gauci AJ, Pastore-Celentano L, ECDC country experts for pneumococcal disease.
    Vaccine; 2014 Jun 17; 32(29):3644-50. PubMed ID: 24795228
    [Abstract] [Full Text] [Related]

  • 20. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.
    Phongsamart W, Srifeungfung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Sricharoenchai S, Chokephaibulkit K.
    Hum Vaccin Immunother; 2014 Jun 17; 10(7):1866-73. PubMed ID: 25424794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.